Skip to main content

Table 1 Clinico-pathological characteristics of the included 100 patients

From: Clinico-pathological significance of immunohistochemically marked tumor-associated macrophage in classic Hodgkin lymphoma

Item Value Percentage
Age (median) 33 (15–74) years
Gender Male: female 37%: 63%
HB level ≥ 10.5 g/dl 64%
< 10.5 g/dl 36%
WBC ≥ 15 × 109/l 15%
< 15 × 109/l 85%
Serum albumin <4 g/dl 35%
≥4 g/dl 65%
HCV antibodies Positive 14%
Negative 86%
Performance status <2 95%
≥2 5%
B symptoms Absent 46%
Present 54%
Bulky disease No 89%
Yes 11%
Histopathology subtype Mixed cellularity 46%
Nodular sclerosis 42%
Lymphocyte rich 12%
Extra nodal disease No 73%
Yes 27%
Spleen involvement No 78%
Yes 22%
Bone marrow involvement No 96%
Yes 4%
Ann Arbor stage I 1%
II 27%
III 42%
IV 30%
Stage Limited 21%
Advanced 79%
IPS < 3 60%
≥ 3 40%
CD 68 I 41%
II 41%
III 18%
CD 163 I 37%
II 40%
III 23%
Response CR 61%
PR 12%
PD 7%
SD 20%
Relapse after CR Yes:no 20%:41%
Status Alive:dead 82%:18%
  1. HB hemoglobin, WBC white blood cell count, HCV, hepatitis C virus, CR complete response, PR partial Response, PD progressive disease, SD stationary disease, IPS International Prognostic score